You are here

Article Text

Article menu

Download PDFPDF

Short report
Long-term clinical and positron emission tomography outcome of fetal striatal transplantation in Huntington’s disease
Free
  1. I Reuter1,
  2. Y F Tai2,
  3. N Pavese2,
  4. K R Chaudhuri1,
  5. S Mason3,
  6. C E Polkey1,
  7. C Clough1,
  8. D J Brooks2,
  9. R A Barker3,
  10. P Piccini2
  1. 1
    Academic Department of Neuroscience, Kings College Hospital, London, UK
  2. 2
    Neurology Group, MRC Clinical Sciences Centre, Cyclotron Building, Imperial College London, Hammersmith Hospital, London, UK
  3. 3
    Cambridge Centre for Brain Repair and Department of Neurology, Forvie Site, Cambridge, UK
  1. Dr P Piccini, Cyclotron Building, Hammersmith Hospital, Du Cane Road, London W12 0NN, UK; paola.piccini{at}imperial.ac.uk

Abstract

Two patients with moderate Huntington’s disease (HD) received bilateral fetal striatal allografts. One patient demonstrated, for the first time, increased striatal D2 receptor binding, evident with 11C-raclopride positron emission tomography, and prolonged clinical improvement over 5 years, suggesting long term survival and efficacy of the graft. The other patient did not improve clinically or radiologically. Our results indicate that striatal transplantation in HD may be beneficial but further studies are needed to confirm this.

https://doi.org/10.1136/jnnp.2007.142380

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • The appendix is published online only at http://jnnp.bmj.com/content/vol79/issue8

    • Funding: The study was funded by the Medical Research Council, UK. YFT was funded by the Wellcome Trust (GR071659AIA).

    • Competing interests: None.

    • Ethics approval: The study received approval from the local research ethics committees.